Marked Amine and Amine Metabolite Changes in Norrie Disease Patients with an X‐Chromosomal Deletion Affecting Monoamine Oxidase
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Urinary and plasma amines and amine metabolites were quantified in two individuals with Norrie disease resulting from a deletion in chromosomal region Xp 11.3, recently reported to be associated with absence of the gene encoding monoamine oxidase (MAO)‐A and nondetectable MAO‐A activity in fibroblasts and MAO‐B activity in platelets. Marked (four‐ to 100‐fold) elevations in levels of urinary phenylethylamine, o‐tyramine, and m‐tyramine (which are preferential substrates for MAO‐B) and marked reductions (90%) in levels of 3‐methoxy‐4‐hydroxyphenylglycol (a deaminated metabolite of norepinephrine, a preferential substrate for MAO‐A) in urine and plasma confirmed the presence of a systemic, functionally significant reduction in the activities of both MAO isozymes. The magnitude of these changes, which are equivalent to those found in subjects taking MAO‐inhibiting antidepressants, suggests that early initiation of dietary and drug restrictions may be clinically important in these and other patients with X‐chromosomal mutations involving MAO. These findings further support the proposition that the MAOA and MAOB genes are located in close proximity on the X chromosome. Negligible changes in the metabolites of dopamine and serotonin raise the possibility that other metabolic pathways are of importance for their production, that dietary or intestinal bacterial sources contribute substantially to the presence of these amine metabolites in urine, or both.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Catecholamine metabolism: basic aspects and clinical significance.
Kopin, I. J. (1985) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06859-0 · Cited by 582
Cited by
Serotonin as a developmental signal
Whitaker-Azmitia, P. M., Druse, M., Walker, P., & Lauder, J. M. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00071-x · Cited by 356
Biochemistry and genetics of monoamine oxidase
Weyler, W., Hsu, Y.-P. P., & Breakafield, X. O. (1990) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(90)90064-9 · Cited by 312
Reactive Oxygen-Related Diseases: Therapeutic Targets and Emerging Clinical Indications
Casas, A. I., Dao, V. T.-V., Daiber, A., Maghzal, G. J., Di Lisa, F., Kaludercic, N., Leach, S., Cuadrado, A., Jaquet, V., Seredenina, T., et al. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6433 · Cited by 136
Eisenhofer, G., Friberg, P., Pacak, K., Goldstein, D. S., Murphy, D. L., Tsigos, C., Quyyumi, A. A., Brunner, H. G., & Lenders, J. W. M. (1995) · Clinical Science · doi:10.1042/cs0880533 · Cited by 123
Self-citation
Metadata
- Authors
- Murphy, D. L., Sims, K. B., Karoum, F., de la Chapelle, A., Norio, R., Sankila, E. ‐., & Breakefield, X. O.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 1990-01
- Volume
- 54
- Issue
- 1
- Pages
- 242-247
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2054637867
- Cited by
- 53
- References
- 1
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Marked Amine and Amine Metabolite Changes in Norrie Disease Patients with an X‐Chromosomal Deletion Affecting Monoamine Oxidase. https://app.cochat.ai/papers/10.1111/j.1471-4159.1990.tb13307.x
- The paper
- Murphy, D. L., Sims, K. B., Karoum, F., de la Chapelle, A., Norio, R., Sankila, E. ‐., & Breakefield, X. O. (1990). Marked Amine and Amine Metabolite Changes in Norrie Disease Patients with an X‐Chromosomal Deletion Affecting Monoamine Oxidase. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.1990.tb13307.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.